Related Experiment Video
Updated: Aug 22, 2025

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
719
Aging Increases Susceptibility to Develop Cardiac Hypertrophy following High Sugar Consumption
Ana P Valencia1, Jeremy A Whitson2, Shari Wang3
1Department of Radiology, University of Washington, Seattle, WA 98109, USA.
Nutrients
|November 11, 2022
Summary
A high-sucrose diet accelerates heart problems in aging mice. The drug elamipretide prevented these diet-induced heart issues, suggesting a potential therapeutic target for aged hearts.
Area of Science:
- Cardiovascular Biology
- Aging Research
- Mitochondrial Medicine
Background:
- Aging and poor diet are known risk factors for heart disease.
- Aging impairs mitochondrial function, leading to cardiac remodeling and sarcopenia.
- The specific impact of high-sucrose diets on the aging heart remains understudied.
Purpose of the Study:
- To investigate the effects of a high-sucrose (HS) diet on cardiac function in aging mice.
- To determine if the mitochondrial-targeted drug elamipretide (ELAM) can prevent HS diet-induced cardiac dysfunction in aged hearts.
Main Methods:
- 24-month-old male CB6F1 mice were fed a HS diet (60% kcal sucrose) or chow for up to 4 weeks.
- Cardiac hypertrophy was assessed by heart weight.
- Mice were treated with elamipretide (ELAM) or saline control.
- Mitochondrial respiration and reactive oxygen species (ROS) production were measured.
Main Results:
- HS diet induced significant cardiac hypertrophy in old mice within one week, which persisted.
- Old mice on HS diet showed accelerated declines in body weight and strength.
- ELAM treatment prevented HS diet-induced cardiac hypertrophy in old mice.
- HS diet did not significantly affect cardiac hypertrophy in young mice.
- Mitochondrial respiration and ROS production were altered by age but not significantly affected by HS diet or ELAM.
Conclusions:
- The aged heart is particularly vulnerable to the detrimental effects of high-sucrose diets.
- Elamipretide demonstrates potential in preventing diet-induced cardiac dysfunction in aging individuals.
- Targeting mitochondria systemically may offer a therapeutic strategy for mitigating the impact of poor diet on the aging heart.
Related Concept Videos
Heart Failure II: Pathophysiology
31
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Imbalances in Cardiac Output
1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
37
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Coronary Artery Disease I: Introduction
46
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Heart Failure I: Introduction
43
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
43

